As drug carriers, liposomes have great potential in that selective tar
geting and release rate control of drugs can be performed by appropria
te modifications to the carrier itself, without altering the structure
of original drugs. In this paper, factors determining the disposition
of liposomes were discussed in relation to the underlying mechanisms.
Selective targetings of liposomes to specific tissues such as hepatoc
ytes, macrophages and tumors were also evaluated based on the in vitro
as well as in vivo data. Finally, the perspective of intracellular dr
ug delivery was also discussed from the mechanistic as well as kinetic
points of view for the development of intracellular targetable drug c
arriers.